Clinical Trials Browser

Phase 2/3 × Palliative Care × Other hematologic neoplasm × Clear all

NCT03870750 2026-01-12

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Phase 2/3 Terminated

Other hematologic neoplasm

Hematologic Neoplasms

NCT05404906 2022-08-19

AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute